Erratum: Corrigendum to “Clinical and biochemical indicators of homeostasis model assessment estimated insulin resistance in postmenopausal women” (Journal of the Chinese Medical Association (2011) 74(10) (442–447) (S172649011100219X) (10.1016/j.jcma.2011.08.014));Clinical and biochemical indicators of homeostasis model assessment-estimated insulin resistance in postmenopausal women

Journal of the Chinese Medical Association

Volumn 74, Issue 10, 2011, Pages 442-447

  Lin, Kuan Hung ^a   Liou, Teh Ling ^b   Hsiao, Li Chuan ^b   Hwu, Chii Min ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Homeostasis model assessment; Insulin resistance; Menopause; Uric acid; Waist circumference

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL ASSESSMENT TOOL; CLINICAL INDICATOR; DIABETES MELLITUS; DISEASE PREDISPOSITION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HIGH RISK POPULATION; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; SENSITIVITY AND SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 80955137885     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2016.06.002     Document Type: Erratum

References (27)

1. Lerner D.J., Kannel W.B. Pattern of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986, 111:383-390.
2. Carr M.C. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003, 88:2404-2411.
3. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
4. Wallace T.M., Levy J.C., Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495.
5. Lejsková M., Alušík S., Suchánek M., Žecová S., Piťha J. Menopause: clustering of metabolic syndrome components and population changes in insulin resistance. Climacteric 2011, 14:83-91.
6. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Meigs J.B., et al. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population. The Bruneck Study. Diabetes Care 2007, 30:318-324.
7. Rutter M.K., Wilson P.W.F., Sullivan L.M., Fox C.S., D'Agostino R.B., Meigs J.B. Use of alternative thresholds defining insulin resistance to predict type 2 diabetes mellitus and cardiovascular disease. Circulation 2008, 117:1003-1009.
8. Song Y., Manson J.E., Tinker L., Howard B.V., Kuller L.H., Nathan L., et al. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women. The women's health initiative observational study. Diabetes Care 2007, 30:1747-1752.
9. Ausk K.J., Boyko E.J., Ioannou G.N. Insulin resistance predicts mortality in nondiabetic individuals in the U.S. Diabetes Care 2010, 33:1179-1185.
10. McLaughlin T.L., Reaven G.M. Beyond type 2 diabetes: the need for a clinically useful way to identify insulin resistance. Am J Med 2003, 114:501-502.
11. Hwu C.M., Fuh J.L., Hsiao C.F., Wang S.J., Lu S.R., Wei M.C., et al. Waist circumference predicts metabolic cardiovascular risk in postmenopausal Chinese women. Menopause 2003, 10:73-80.
12. Balkau B., Charles M.A., Drivsholm T., Borch-Johnsen K., Wareham N., Yudkin J.S., et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabete Metab 2002, 28:364-376.
13. Kramer M.S. Clinical epidemiology and biostatistics: a primer for clinical investigators and decision-makers 1988, Springer-Verlag, New York.
14. Shaw J.E., Hodge A.M., de Courten M., Chitson P., Zimmet P.Z. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia 1999, 42:1050-1054.
15. Qiao Q., Tuomilehto J., Borch-Johnsen K. Post-challenge hyperglycaemia is associated with premature death and macrovascular complications. Diabetologia 2003, 46(suppl):M17-M21.
16. McFarlane S.I., Banerji M., Sowers J.R. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 2001, 86:713-718.
17. Manley S.E., Stratton I.M., Clark P.M., Luzio S.D. Comparison of 11 human insulin assays: implications for clinical investigation and research. Clin Chem 2007, 53:922-932.
18. Reaven G. Wanted! A standardized measurement of plasma insulin concentration. Arterioscler Thromb Vasc Biol 2011, 31:954-955.
19. Chou P., Lin K.C., Lin H.Y., Tsai S.T. Gender differences in the relationships of serum uric acid with fasting serum insulin and plasma glucose in patients without diabetes. J Rheumatol 2001, 28:571-576.
20. Bonora E., Capaldo B., Perin P.C., Del Prato S., De Mattia G., Frittitta L., et al. Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database. Nutr Metab Cardiovasc Dis 2008, 18:624-631.
21. Facchini F., Chen Y.D., Hollenbeck C.B., Reaven G.M. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. J Am Med Assoc 1991, 266:3008-3011.
22. Tsouli S.G., Liberopoulos E.N., Mikhailidis D.P., Athyros V.G., Elisaf M.S. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?. Metabolism 2006, 55:1293-1301.
23. Kramer C.K., von Mühlen D., Jassal S.K., Barrett-Connor E. A prospective study of uric acid by glucose tolerance status and survival: the Rancho Bernardo Study. J Intern Med 2010, 267:561-566.
24. Nilsson G., Hedberg P., Jonaon T., Lönnberg I., Tenerz Å., Forberg R., et al. Waist circumference alone predicts insulin resistance as good as the metabolic syndrome in elderly women. Eur J Intern Med 2008, 19:520-526.
25. Lear S.A., James P.T., Ko G.T., Kumanyika S. Appropriateness of waist circumference and waist-to-hip ratio cutoffs for different groups. Eur J Clin Nutr 2010, 64:42-61.
26. Bao Y., Lu J., Wang C., Yang M., Li H., Zhang X., et al. Optimal waist circumference cutoffs for abdominal obesity in Chinese. Atherosclerosis 2008, 201:378-384.
27. Alberti K.G.M.M., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome. A joint interim statement of the International diabetes federation task force on epidemiology and prevention; National heart, Lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; and International association for the study of obesity. Circulation 2009, 120:1640-1645.